CVS Health Corp. buy Mizuho
Summary
This prediction ended on 25.10.25 with a price of €70.93. The BUY prediction by Mizuho for CVS Health Corp. saw massive gains of 35.23%. Mizuho has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €0.64 was paid as dividends for this prediction. Mizuho has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -4.225% | -4.225% | 41.993% |
| iShares Core DAX® | 2.222% | 1.039% | 2.437% |
| iShares Nasdaq 100 | 0.486% | 11.722% | 33.370% |
| iShares Nikkei 225® | -2.972% | 5.236% | 43.627% |
| iShares S&P 500 | 0.555% | 5.990% | 22.517% |
Comments by Mizuho for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.